1st Annual International HPV Awareness Day; Spreading Knowledge and Prevention Around the Globe

admin
admin
· 3 min read
1st Annual International HPV Awareness Day

Last Sunday, March 4th, marked the 1st annual International HPV Awareness Day, organized by the International Papillomavirus Society (IPVS) and its global partners. The goal of the day is to spark conversation and promote a worldwide exchange of ideas, knowledge and research-based information about human papillomaviruses (HPV) and their associated diseases. This is the first year of the new annual awareness day, which will take place every March 4th going forward with a specific focus each year.

The campaign is “Give Love, Not HPV.” We believe love is the foundation of a happy and healthy life. Whether it’s familial love, love between friends or romantic love, it’s important to protect the ones who matter most. By increasing awareness of the risks of the virus worldwide, we will create a movement to fight back with: “Give Love, Not HPV”.

“There are countless things we want to give our loved ones,” Silvia De San Jose, President of IPVS explained, “protection, comfort, and security. But we don’t want to give them something that is hard to talk about: HPV. This day is about spreading knowledge to people around the world about human papillomaviruses and their associated diseases, and the measures that they can take to protect themselves and their loved ones.”

Human papillomaviruses (HPVs) are sexually transmitted viruses that are very common worldwide. There are more than 200 different HPV types, and most sexually active men and women will acquire at least one genital HPV type at some point in their lifetime. Some types of HPVs are known to cause certain cancers such as cervical, anal and oropharyngeal cancer. Worldwide, cervical cancer is the fourth most frequent cancer in women and an estimated 270,000 women die of cervical cancer every year.

This year’s Awareness Day will focus on a variety of countries around the world. The problems associated with HPV affect people in both developed and developing countries, however, prevention options vary. In developed countries, there are several approaches to prevention of HPV-related cancers. One approach is the HPV vaccination, which effectively prevents infection with HPV. Others, such as HPV testing and cervical Pap smear screening, are aimed at individuals who may already have been exposed to HPV.

In developing countries, there is limited access to both of these prevention approaches.  Cancer is often diagnosed at an advanced stage and prospects for treatment may be poor, resulting in a higher rate of death from cervical cancer in these countries. Even in developed countries access to prevention, screening and treatment vary and the impact of HPV is felt disproportionately in poorer communities.

Men can contract and transmit cancer-causing HPV as well. For men who have sex with men, the risk of developing anal cancer after contracting HPV is comparable to cervical cancer in women infected by HPV.

Dr. Joel Palefsky, Chairman of the IPVS International HPV Awareness Day campaign committee, summarized the purpose of the day. “HPV Awareness Day will share information about HPV and prevention and treatment options. It will also help to connect people to local organizations that are helping to save lives. HPV affects everyone and we can all take steps to care for one another – we know what works. On March 4th our aim is to inspire conversations and build global commitment to combat this silent killer.”

Read Next

India successfully validates the first indigenous HPV test for Cervical Cancer screening
News
June 13, 2026

India successfully validates the first indigenous HPV test for Cervical Cancer screening

India has achieved a significant milestone in cervical cancer prevention with the successful validation of the country’s first indigenous HPV DNA tests, which meet international standards for cervical cancer screening. Published in the International Journal of Cancer, a multicentre study involving leading Indian and international institutions found that Molbio Diagnostics Truenat HPV-HR Plus met the […]
Article by: IMT News Desk
Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris
News
June 12, 2026

Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris

Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd., has announced the launch of Winlevi® (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the treatment of acne vulgaris in both adults and adolescents aged 12 to <18 years (with usage in […]
Article by: IMT News Desk
Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory
News
June 12, 2026

Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory

Thyrocare Technologies Limited has announced the set-up of its new diagnostic laboratory in Prayagraj, Uttar Pradesh, in association with SecondMedic. The new laboratory is equipped with advanced testing infrastructure and supported by trained professionals, enabling timely and error-free diagnostic results. It caters to both specialised and routine testing requirements, offering support to ongoing and preventive […]
Article by: IMT News Desk
AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer
News
June 12, 2026

AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer

AstraZeneca Pharma India Ltd. (AZPIL) announced that the Central Drugs Standard Control Organisation (CDSCO) has approved an additional indication for Trastuzumab Deruxtecan 100 mg/5 mL vial lyophilized powder for concentrate for solution for infusion, in combination with Pertuzumab as a first-line treatment for adult patients with unresectable or metastatic HER2-positive (IHC 3+ or ISH+) breast cancer. In India, HER2-positive breast […]
Article by: IMT News Desk